Start Submission Become a Reviewer

Reading: Pharmaceutical information: Does the Directive 2001/83/EC protect such a right for the end u...

Download

A- A+
Alt. Display

Scientific Articles

Pharmaceutical information: Does the Directive 2001/83/EC protect such a right for the end user?

Author:

Andrea Faeh

University of Fribourg, CH; University of Copenhagen, DK
About Andrea
Andrea Faeh has recently defended her Doctoral Dissertation at the School of Law, University of Fribourg (Switzerland). She is a Postdoctoral Research at the Faculty of Law, University of Copenhagen (Denmark) and conducts research in the area of European pharmaceutical legislation
X close

Abstract

The right to information is of crucial importance for the end-user of pharmaceuticals to exercise their right of self-determination. In the Directive 2001/83/EC relating to pharmaceuticals for human use all the particulars that have to be on the labelling or in the package leaflet are stipulated and need to be transposed into national law.

This contribution scrutinises first the implications that a correct implementation of the information rules entails for the legal position of the individual. Second, the conditions and consequences of a failed implementation will be equally assessed in order to evaluate the legal impact when the right to information is violated by the state or the marketing authorisation holder.

How to Cite: Faeh, A., 2011. Pharmaceutical information: Does the Directive 2001/83/EC protect such a right for the end user?. Amsterdam Law Forum, 3(1), pp.30–41. DOI: http://doi.org/10.37974/ALF.160
51
Views
18
Downloads
Published on 02 Feb 2011.
Peer Reviewed

Downloads

  • PDF (EN)

    comments powered by Disqus